Last year a South African woman took a multibillion-dollar United States pharmaceutical company to court with the aim of securing access to life-changing cystic fibrosis medicines. That case has now been dropped following a reduction in the price charged for the medicines in South Africa. Catherine Tomlinson reports.
2023 was a busy year for healthcare in South Africa. We saw several promising policy developments, landmark court cases, important pieces of legislation, and some changes in leadership. Yet, take a step back and at facility level little seems to have changed. Shortages of healthcare workers persist, corruption is still rife, budgets tight, and our health governance crisis remains as acute as ever. Marcus Low looks back at the year in health in fewer than 1 000 words.
A pivotal case for access to affordable medicines in South Africa is set to determine whether people in South Africa will be able to get access to breakthrough cystic fibrosis treatments. Aneesa Adams spent some time with a family living with cystic fibrosis to get a sense of what is at stake.
Johannesburg-based investment banker Cheri Nel is the driving force behind a court case that may result in dramatically expanded access to life-changing new cystic fibrosis (CF) medicines. Biénne Huisman asked Nel about the motivation behind the court case and what it is like to live with CF.
Spotlight recently reported on a court case aimed at expanding access to breakthrough new treatments for cystic fibrosis (CF) and on how this debilitating disease is diagnosed in South Africa. Now, in Part 3 of this special series on CF, Catherine Tomlinson turns the spotlight on how the disease is currently being treated in the country, while the new treatments are still largely out of reach.
In recent weeks, cystic fibrosis (CF) has been in the headlines because of a court case about access to new treatments for the genetic condition. After having reported on the court case, Catherine Tomlinson now unpacks how CF is diagnosed in South Africa and why so many cases here fall through the cracks. The good news, she reports, is that efforts are underway to establish a national infant screening programme.
Cystic fibrosis (CF) is a debilitating and often deadly disease. Until recently, the only treatments for its symptoms were difficult to administer and time-consuming. Life-changing new treatments that dramatically improve the prognosis for people with the disease have been developed, but they are expensive and Vertex, the US company making the drugs, has decided against registering the drugs in South Africa. Cheri Nel, a woman living with CF, is now taking Vertex on in a South African court. Catherine Tomlinson unpacks the details.
